Drug Shortage Report for NRA-OLMESARTAN
| Report ID | 248764 |
| Drug Identification Number | 02499266 |
| Brand name | NRA-OLMESARTAN |
| Common or Proper name | NRA-Olmesartan |
| Company Name | NORA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OLMESARTAN MEDOXOMIL |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90's |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-24 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1565 LIONEL-BOULET BLVD. VARENNES, QUEBEC CANADA J3X 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-04-08 | French | Compare |
| v3 | 2025-04-08 | English | Compare |
| v2 | 2025-01-28 | French | Compare |
| v1 | 2025-01-28 | English | Compare |
Showing 1 to 4 of 4